Related Experiment Video
Updated: Oct 25, 2025
Point-Of-Care Ultrasound Screening for Proximal Lower Extremity Deep Venous Thrombosis
Published on: February 10, 2023
Executive Summary: Antithrombotic Therapy for VTE Disease: Second Update of the CHEST Guideline and Expert Panel
Scott M Stevens1, Scott C Woller1, Lisa Baumann Kreuziger2
1Department of Medicine, Intermountain Healthcare, Murray, UT.
Insights
This updated guideline provides 29 recommendations on the antithrombotic management of venous thromboembolism (VTE), including 13 strong recommendations and four new guidance statements. It addresses 17 PICO questions to inform patient care.
Area of Science:
- Clinical Medicine
- Hematology
- Pharmacology
Background:
- This document represents the second update to the ninth edition of clinical guidelines.
- It addresses 17 Population, Intervention, Comparator, Outcome (PICO) questions relevant to venous thromboembolism (VTE) management.
- Four of these PICO questions are new and have not been previously covered.
Purpose of the Study:
- To provide updated recommendations for the antithrombotic management of VTE.
- To incorporate new evidence and address evolving clinical questions.
- To guide clinical decision-making in the secondary prevention and risk reduction of VTE and its complications.
Main Methods:
- Recommendations were developed using the Grading of Recommendations, Assessment, Development, and Evaluation (GRADE) methodology.
- Evidence certainty was categorized as high, moderate, or low to generate strong and weak recommendations.
- A panel systematically reviewed new evidence to inform guidance statements.
Main Results:
- A total of 29 guidance statements were generated, with 13 classified as strong recommendations.
- The recommendations cover the spectrum of VTE management, from initial treatment to long-term secondary prevention.
- Eight statements were substantially revised from previous updates, and four new statements were added.
Conclusions:
- New evidence since 2016 has refined the standard of care for VTE patients.
- Significant uncertainties persist in managing VTE, particularly in specific patient subgroups and limited disease scenarios.
- These updated guidelines aim to improve the management and outcomes for patients with VTE.
Background:
This is the 2nd update to the 9th edition of these guidelines. We provide recommendations on 17 PICO (Population, Intervention, Comparator, Outcome) questions, four of which have not been addressed previously.
Methods:
We generate strong and weak recommendations based on high-, moderate-, and low-certainty evidence, using GRADE (Grading of Recommendations, Assessment, Development, and Evaluation) methodology.
Results:
The panel generated 29 guidance statements, 13 of which are graded as strong recommendations, covering aspects of antithrombotic management of VTE from initial management through secondary prevention and risk reduction of postthrombotic syndrome. Four new guidance statements have been added that did not appear in the 9th edition (2012) or 1st update (2016). Eight statements have been substantially modified from the 1st update.
Conclusion:
New evidence has emerged since 2016 that further informs the standard of care for patients with VTE. Substantial uncertainty remains regarding important management questions, particularly in limited disease and special patient populations.
Related Concept Videos
01:29Venous Thrombosis III: Interprofessional Care
01:29Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
01:20Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
01:27Pulmonary Embolism III: Nursing Management
01:30Venous Thrombosis IV: Nursing Management
01:30Venous Thrombosis I: Introduction